Aarti Drugs Limited (AARTIDRUGS)
₹474.75
INR+5.80(+1.24%)
As of June 3, 2025 4:40:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹4061.06 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹4648.10 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
24.21
Forward P/E
Price to Earnings ratio based on forecasted earnings
15.68
PEG Ratio
Price/Earnings to Growth ratio
-21.40
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.70
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
35.44%
Operating Margin
Operating income as a percentage of revenue
11.87%
Return on Equity
Net income as a percentage of shareholders' equity
12.68%
Revenue (TTM)
Total revenue over trailing 12 months
₹2387.03 Cr+9.2%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹303.42 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹18.33+32.9%
Balance Sheet
Total Cash
Total cash and short-term investments
₹22.61 Cr
Total Debt
Total short-term and long-term debt
₹615.07 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
44.92%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹312 - ₹635
Beta
Measure of stock's volatility compared to the market
0.48
Shares Outstanding
Total number of shares issued by the company
₹9.13 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.90%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.23%
Payout Ratio
Percentage of earnings paid as dividends
5.45%
